SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001398344-21-003553
Filing Date
2021-02-16
Accepted
2021-02-16 16:39:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 fp0062370_sc13ga.htm SC 13G/A 117360
2 fp0062370_ex991.htm EX-99.1 3306
  Complete submission text file 0001398344-21-003553.txt   122201
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Subject) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90534 | Film No.: 21639637
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 SEVENTH AVENUE 30TH FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 30TH FLOOR NEW YORK NY 10019 212-257-4410
Sessa Capital (Master), L.P. (Filed by) CIK: 0001618360 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A